These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 9008220)
41. Neutron fluence-to-dose conversion coefficients for embryo and fetus. Chen J; Meyerhof D; Vlahovich S Radiat Prot Dosimetry; 2004; 110(1-4):693-8. PubMed ID: 15353732 [TBL] [Abstract][Full Text] [Related]
42. Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor. Rühm W; Walsh L Radiat Prot Dosimetry; 2007; 126(1-4):423-31. PubMed ID: 17533156 [TBL] [Abstract][Full Text] [Related]
43. Relation of radiation to gastric carcinoma observed in autopsy cases in a fixed population, Hiroshima and Nagasaki, 1961--74. Yamamoto T; Shimizu Y J Radiat Res; 1978 Sep; 19(3):213-27. PubMed ID: 739442 [No Abstract] [Full Text] [Related]
44. Supra-linear dose-response in the A-bomb study. Gofman JW Health Phys; 1989 Dec; 57(6):1037-8. PubMed ID: 2584021 [No Abstract] [Full Text] [Related]
45. Dose-response analyses for the Japanese A-bomb survivors. Muirhead CR; Butland BK Health Phys; 1989 Dec; 57(6):1035-6. PubMed ID: 2584020 [No Abstract] [Full Text] [Related]
46. Dose estimation for atomic bomb survivor studies: its evolution and present status. Cullings HM; Fujita S; Funamoto S; Grant EJ; Kerr GD; Preston DL Radiat Res; 2006 Jul; 166(1 Pt 2):219-54. PubMed ID: 16808610 [TBL] [Abstract][Full Text] [Related]
47. Mammary neoplasia in the rat following high-energy neutron irradiation. Montour JL; Hard RC; Flora RE Cancer Res; 1977 Aug; 37(8 Pt 1):2619-23. PubMed ID: 872090 [No Abstract] [Full Text] [Related]
48. Estimation of whole-body doses by means of chromosome aberrations observed in survivors of the Hiroshima A-bomb. Randolph ML; Brewen JG Radiat Res; 1980 May; 82(2):393-407. PubMed ID: 7375639 [No Abstract] [Full Text] [Related]
49. Europium-152 activity induced by Hiroshima atomic bomb neutrons: comparison with the 32P, 60Co, and 152Eu activities in dosimetry system 1986 (DS86). Hoshi M; Yokoro K; Sawada S; Shizuma K; Iwatani K; Hasai H; Oka T; Morishima H; Brenner DJ Health Phys; 1989 Nov; 57(5):831-7. PubMed ID: 2592219 [No Abstract] [Full Text] [Related]
50. Cancer and non-cancer effects in Japanese atomic bomb survivors. Little MP J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804 [TBL] [Abstract][Full Text] [Related]
51. Relative biological effectiveness of 280 keV neutrons for apoptosis in human lymphocytes. Ryan LA; Wilkins RC; McFarlane NM; Sung MM; McNamee JP; Boreham DR Health Phys; 2006 Jul; 91(1):68-75. PubMed ID: 16775482 [TBL] [Abstract][Full Text] [Related]
52. Dose measurements around spallation neutron sources. Fragopoulou M; Stoulos S; Manolopoulou M; Krivopustov M; Zamani M Radiat Prot Dosimetry; 2008; 132(3):277-82. PubMed ID: 18957519 [TBL] [Abstract][Full Text] [Related]
53. [Low-dose ionising radiation and cancer risk]. Auvinen A; Hakama M; Rytömaa T Duodecim; 1998; 114(6):505, 507. PubMed ID: 11466913 [No Abstract] [Full Text] [Related]
54. Radiation science. Sparks fly over new report on Hiroshima bomb radiation. Normile D Science; 2003 Aug; 301(5634):742. PubMed ID: 12907763 [No Abstract] [Full Text] [Related]
55. Secondary neutrons in clinical proton radiotherapy: a charged issue. Brenner DJ; Hall EJ Radiother Oncol; 2008 Feb; 86(2):165-70. PubMed ID: 18192046 [TBL] [Abstract][Full Text] [Related]
56. Hiroshima - the effects of the atom bomb. McClelland M Nurs Mirror; 1977 Sep; 145(9):19-22. PubMed ID: 587385 [No Abstract] [Full Text] [Related]